Spatial distribution of tissue inhibitor of metalloproteinase-1 mRNA in chronic liver disease

Journal of Hepatology

Volumn 30, Issue 3, 1999, Pages 425-432

  Yata, Yutaka ^a   Takahara, Terumi ^a   Furui, Kei ^a   Zhang, Li Ping ^a   Jin, Bo ^a   Watanabe, Akiharu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Hepatic fibrosis; Stellate cell; Tissue inhibitor of metalloproteinase 1 (TIMP 1)

Indexed keywords

COLLAGENASE INHIBITOR; METALLOPROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; STELLATE CELL;

EID: 0032997705     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80101-9     Document Type: Article

References (37)

1. Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. [review] N Engl J Med. 328:1993;1828-1835.
2. Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. [review] Am J Respir Cell Mol Biol. 7:1992;120-125.
3. Nakatsukasa H, Ashida K, Higashi T, Ohguchi S, Tsuboi S, Hino N, et al. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas. Hepatology. 24:1996;82-88.
4. Roeb E, Graeve L, Hoffmann R, Decker K, Edwards DR, Heinrich PC. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology. 18:1993;1437-1442.
5. Iredale JP, Murphy G, Hembry RM, Friedman SL, Arthur MJ. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest. 90:1992;282-287.
6. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, et al. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol. 150:1997;1647-1659.
7. Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New Inuyama classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 6:1996;112-119.
8. Takahara T, Furui K, Yata Y, Jin B, Zhang LP, Nambu S, et al. Dual expression of matrix metalloproteinase-2 and membrane-type 1 matrix metalloproteinase in fibrotic human livers. Hepatology. 26:1997;1521-1529.
9. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene. 7:1992;77-83.
10. Ponte P, Gunning P, Blau H, Kedes L. Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3′ untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol. 3:1983;1783-1791.
11. Cox KH, Deleon DV, Angerer LM, Angerer RC. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol. 101:1984;485-502.
12. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:1979;5294-5299.
13. Aviv H, Leder P. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA. 69:1972;1408-1412.
14. Thomas PS. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA. 77:1980;5201-5205.
15. Takahara T, Nakayama Y, Itoh H, Miyabayashi C, Watanabe A, Sasaki H, et al. Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study. Liver. 12:1992;368-380.
16. Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology. 24:1996;176-184.
17. Ueno T, Tamaki S, Sugawara H, Inuzuka S, Torimura T, Sata M, et al. Significance of serum tissue inhibitor of metalloproteinases-1 in various liver diseases. J Hepatol. 24:1996;177-184.
18. Murawaki Y, Ikuta Y, Nishimura Y, Koda M, Kawasaki H. Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: a comparative analysis. J Hepatol. 23:1995;145-152.
19. Maruyama K, Feinman L, Okazaki I, Lieber CS. Direct measurement of neutral collagenase activity in homogenates from baboon and human liver. Biochim Biophys Acta. 658:1981;124-131.
20. Maruyama K, Feinman L, Fainsilber Z, Nakano M, Okazaki I, Lieber CS. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci. 30:1982;1379-1384.
21. Emonard H, Grimaud JA. Active and latent collagenase activity during reversal of hepatic fibrosis in murine schistosomiasis. Hepatology. 10:1989;77-83.
22. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJ. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology. 110:1996;821-831.
23. Arai M, Niioka M, Maruyama K, Wada N, Fujimoto N, Nomiyama T, et al. Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon. Dig Dis Sci. 41:1996;995-1000.
24. Nakano Y, Kiyosawa K, Sodeyama T, Tanaka E. Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis. Am J Gastroenterol. 85:1990;24-29.
25. Omata M, Ito Y, Yokosuka O, Imazeki F, Uchiumi K, Takano S, et al. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B. Dig Dis Sci. 34:1989;330-337.
26. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, et al. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology. 101:1991;497-502.
27. Enzan H, Himeno H, Iwamura S, Saibara T, Onishi S, Yamamoto Y, et al. Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver. Virchows Arch. 424:1994;249-256.
28. Yamada H, Aida T, Taguchi K, Asano G. Expression of prolyl 4-hydroxylase, type III and IV procollagen mRNAs in fibrotic human liver. Acta Hepatol Jpn. 32:1991;358-365.
29. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS. Cellular distribution of transforming growth factorbeta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 85:1990;1833-1843.
30. Edwards DR, Murphy G, Reynolds JJ, Whitham S E, Docherty AJ, Angel P, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;1899-1904.
31. Overall CM. Regulation of tissue inhibitor of matrix metalloproteinase expression. Ann N Y Acad Sci. 732:1994;51-64.
32. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 298:1992;29-32.
33. Nemeth JA, Rafe A, Steiner M, Goolsby CL. TIMP-2 growthstimulatory activity: a concentration- and cell type-specific response in the presence of insulin. Exp Cell Res. 224:1996;110-115.
34. Docherty AJ, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJ, et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature. 318:1985;66-69.
35. Schnaper HW, Grant DS, Stetler-Stevenson WG, Fridman R, D'Orazi G, Murphy AN, et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J Cell Physiol. 156:1993;235-246.
36. DeClerck YA, Yean TD, Chan D, Shimada H, Langley KE. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. Cancer Res. 51:1991;2151-2157.
37. Ponton A, Coulombe B, Skup D. Decreased expression of tissue inhibitor of metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res. 51:1991;2138-2143.